A discussion from the researcher behind the trial cited as the ‘The Key to Longevity’
Meet the cardiologist and scientist behind the groundbreaking Kisel-10 study, which demonstrated a difference in microRNA and telomeres in elderly people who received selenium and Q10 supplements (or a placebo). The results of this study are so distinct and comprehensive, that it led to 20 sub-studies!
Through the Kisel-10 study, 443 Swedish participants between the ages of 70 and 87 received either a placebo or 200mg of Bio-Quinone and 200mcg of SelenoPrecise, every day for four years. Subsequently, one could see the significant differences between the two groups concerning important health markers.
In addition to following up on the participants 10 and 12 years after the start of the project, blood samples have been studied and have been able to provide many interesting answers to what difference the two supplements have made on a cellular level.
About the events:
The seminars will take place on:
Thursday 1st of June 2023 at The Lowry, Manchester
(afternoon seminar 12.30pm to 4pm and evening seminar 6pm to 9.30pm)
Wednesday 14th of June 2023 at The Royal Society of Medicine, London
(afternoon seminar 12.30pm to 4pm and evening seminar 6pm to 9.30pm)
The event is free to attend
To secure your place visit: click HERE or call 01670 534 900.
About Dr Urban Alehagen
Dr Urban Alehagen is a Professor in Cardiology at the University of Linkoping, Sweden. He is a specialist in internal medicine, cardiology, and odontology. He is the principal investigator for the Kisel-10 study where the effects of supplementation with selenium and coenzyme Q10 has been studied; first demonstrating the clinical positive effects, and then investigating the effects on oxidative stress and inflammation by the supplementation.The results are reported and published.
